Archive for the 'Genitourinary Cancer' Category

Bladder Cancer, Urostomy And Impotence

At approximately $40.00 per volume, we felt one text, maybe two, would have to suffice for the genitourinary section of our admittedly meager home medical library. We finally settled on Genitourinary Cancer by Donald G. …
More: continued here

[Genitourinary Cancer] Systems Pathology Approach for the

For patients with prostate cancer treated by radical prostatectomy, no current personalized tools predict clinical failure (CF; metastasis and/or androgen-independent disease). We developed such a tool through integration of …
More: continued here

[Genitourinary Cancer] Influence of Year of Diagnosis, Patient Age

Of men diagnosed with stage I seminoma from 1990 through 2004, 3125 were identified using the Surveillance, Epidemiology, and End Results cancer registry. A multivariable logistic regression analysis was performed to assess whether …
More: continued here

[Genitourinary Cancer] Gene Panel Model Predictive of Outcome in

In men who are at high-risk of prostate cancer, progression and death from cancer after radical retropubic prostatectomy (RRP), limited prognostic information is provided by established prognostic features. The objective of this study …
More: continued here

Consistent PSA Screening Results In Better Prognosis

… and other published studies - show that PSA screening may be an effective tool in reducing the number of prostate cancer deaths,” said Anthony D’Amico, chief of Genitourinary Radiation Oncology at BWH and senior author of the paper. …
More: continued here

Tissue Distribution of Human AKR1C3 and Rat Homolog in the Adult

Tissue distribution of human AKR1C3 and its rat homolog in adult genitourinary systems including kidney, bladder, prostate, and testis was studied by IHC. A strong immunoreactivity was detected not only in classically hormone-associated …
More: continued here

Novel therapies in genitourinary cancer: an update

In recent years, new treatment for renal cell carcinoma (RCC) has been a spotlight in the field of cancer therapeutics. With several emerging agents branded as ‘targeted therapy’ now available, both medical oncologists and urologists …
More: continued here

September 10, 2008: Join Dana-Farber/Brigham and Women's Cancer

For this webcast, Anthony V. D’Amico, MD, PhD, Chief of the Prostate Cancer Radiation Oncology Service, Philip W. Kantoff, MD, Director of the Lank Center for Genitourinary Oncology, Jerome P. Richie, MD, Chief of Urologic Surgery, …
More: continued here

Cancer Survivors - Dysbiosis is Your Major Obstacle to Cure

The major body systems most sensitive to the yeast are the gastrointestinal, genitourinary, endocrine, nervous and immune systems Allergies have also been attributed to Candida overgrowth, but the worst symptom is malabsorption, …
More: continued here

Taking Opposite Approach To Treat Asthma Part 3

Presented by June Chan, ScD at the American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium - A Multidisciplinary Approach - February 14-16, 2008 San Francisco, California, USA Reported by ebuydrugonline.com …
More: continued here